Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver.

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the basal and inducible expression of a large battery of cytoprotective genes. These gene products include proteins that catalyze reduction reactions (NAD(P)H:quinone oxidoreductase 1, Nqo1), conjugation reactions (glutathione-S-transferases, Gsts and UDP-glucuronosyltransferases, Ugts), as well as the efflux of potentially toxic xenobiotics and xenobiotic conjugates (multidrug resistance-associated proteins, Mrps). The significance of Nrf2 in the liver has been established, as livers of Nrf2-null mice are more susceptible to various oxidative/electrophilic stress-induced pathologies than wild-type mice. In contrast, both pharmacological and genetic models of hepatic Nrf2 activation are protective against oxidative/electrophilic stress. Furthermore, because certain Nrf2-target genes in the liver could affect the distribution, metabolism, and excretion of xenobiotics, the effects of Nrf2 on the kinetics of drugs and other xenobiotics should also be considered, with a special emphasis on metabolism and excretion. Therefore, this review highlights the research that has contributed to the understanding of the importance of Nrf2 in toxicodynamics and toxicokinetics, especially that which pertains to the liver.

[1]  M. Sporn,et al.  The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. , 2005, Cancer research.

[2]  T. Rushmore,et al.  The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. , 1991, The Journal of biological chemistry.

[3]  Donna D. Zhang,et al.  Nrf2 protects against As(III)-induced damage in mouse liver and bladder. , 2009, Toxicology and applied pharmacology.

[4]  Ken Itoh,et al.  Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages* , 2000, The Journal of Biological Chemistry.

[5]  A. Kong,et al.  Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. , 2006, Cancer letters.

[6]  A. Choi,et al.  Parallel Induction of Heme Oxygenase-1 and Chemoprotective Phase 2 Enzymes by Electrophiles and Antioxidants: Regulation by Upstream Antioxidant-Responsive Elements (ARE) , 1995, Molecular medicine.

[7]  M. Sporn,et al.  Activation of nuclear factor E2‐related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development , 2008, Hepatology.

[8]  Y. Kan,et al.  An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Klaassen,et al.  Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. , 2009, Biochemical pharmacology.

[10]  Y. Li,et al.  Antidiabetic and antioxidant effects of oleanolic acid from Ligustrum lucidum Ait in alloxan‐induced diabetic rats , 2009, Phytotherapy research : PTR.

[11]  W. E. Fahl,et al.  Functional characterization of transcription regulators that interact with the electrophile response element. , 2001, Biochemical and biophysical research communications.

[12]  A. Choi,et al.  Nrf2, a Cap’n’Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene* , 1999, The Journal of Biological Chemistry.

[13]  Xingguo Cheng,et al.  Regulation of hepatic bile acid transporters Ntcp and Bsep expression. , 2007, Biochemical pharmacology.

[14]  Paul T Tarr,et al.  Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.

[15]  Masayuki Yamamoto,et al.  Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor‐E2–related factor‐2 transcriptional pathway , 2007, Hepatology.

[16]  K. Ko,et al.  Oleanolic Acid Protects against Myocardial Ischemia-Reperfusion Injury by Enhancing Mitochondrial Antioxidant Mechanism Mediated by Glutathione and α-Tocopherol in Rats , 2005, Planta medica.

[17]  T. Kensler,et al.  Chemoprotection by Organosulfur Inducers of Phase 2 Enzymes: Dithiolethiones and Dithiins , 2000, Drug metabolism and drug interactions.

[18]  S. Nishikawa,et al.  Multivalent DNA Binding Complex Generated by Small Maf and Bach1 as a Possible Biochemical Basis for β-Globin Locus Control Region Complex* , 1998, The Journal of Biological Chemistry.

[19]  P. Bugnon,et al.  Impaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance , 2008, The EMBO journal.

[20]  Jie Liu,et al.  New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction. , 2008, Biochemical pharmacology.

[21]  D. Ross Quinone Reductases Multitasking in the Metabolic World , 2004, Drug metabolism reviews.

[22]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[23]  B. Reddy,et al.  Effect of dietary butylated hydroxyanisole on methylazoxymethanol acetate-induced toxicity in mice. , 1982, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  Xingguo Cheng,et al.  REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS , 2005, Drug Metabolism and Disposition.

[25]  T. Rushmore,et al.  Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Alam,et al.  The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. , 1996, Biochemical and biophysical research communications.

[27]  M. Sporn,et al.  Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. , 2009, European journal of pharmacology.

[28]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[29]  Masayuki Yamamoto,et al.  Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  J. D. Engel,et al.  Long range interaction of cis‐DNA elements mediated by architectural transcription factor Bach1 , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[31]  Y. Kan,et al.  Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Akaza,et al.  Nrf2 Is Essential for the Chemopreventive Efficacy of Oltipraz against Urinary Bladder Carcinogenesis , 2004, Cancer Research.

[33]  Ying Li,et al.  Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. , 1992, The Journal of biological chemistry.

[34]  Y. Liu,et al.  Protective effect of oleanolic acid against chemical-induced acute necrotic liver injury in mice. , 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[35]  L. R. Zhang,et al.  [Antagonistic effect of oleanolic acid on anaphylactic shock]. , 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[36]  M. Sporn,et al.  The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta. , 2006, Molecular cancer therapeutics.

[37]  N. Goto,et al.  Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. , 2009, Biochemical and biophysical research communications.

[38]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[39]  C. Cho,et al.  Modulation of heme oxygenase in tissue injury and its implication in protection against gastrointestinal diseases. , 2001, Life sciences.

[40]  Y. Liu,et al.  The effect of Chinese hepatoprotective medicines on experimental liver injury in mice. , 1994, Journal of ethnopharmacology.

[41]  E C Miller,et al.  Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver. , 1983, Cancer research.

[42]  Jie Liu,et al.  Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice. , 1995, The Journal of pharmacology and experimental therapeutics.

[43]  Curtis D. Klaassen,et al.  INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER , 2005, Drug Metabolism and Disposition.

[44]  A. Meister,et al.  Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. , 1984, The Journal of biological chemistry.

[45]  W. Dekant,et al.  Glutathione-dependent bioactivation of xenobiotics. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[46]  K. Itoh,et al.  Keap1 regulates both cytoplasmic‐nuclear shuttling and degradation of Nrf2 in response to electrophiles , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[47]  T. Fukami,et al.  Transcriptional regulation of human carboxylesterase 1A1 by nuclear factor-erythroid 2 related factor 2 (Nrf2). , 2010, Biochemical pharmacology.

[48]  M. Sporn,et al.  Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[49]  R. Mulcahy,et al.  Identification of a putative antioxidant response element in the 5'-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. , 1995, Biochemical and biophysical research communications.

[50]  K. Kanki,et al.  A crucial role of Nrf2 in in vivo defense against oxidative damage by an environmental pollutant, pentachlorophenol. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  C. Klaassen,et al.  Xenobiotic transporters: ascribing function from gene knockout and mutation studies. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[52]  C. Klaassen,et al.  ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  J. Groopman,et al.  Mechanism of Protection against Aflatoxin Tumorigenicity in Rats Fed 5-(2-Pyrazinyl)-4-methyl-l,2-dithiol-3-thione (Oltipraz) and Related l,2-Dithiol-3-thiones and l , 1987 .

[54]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[55]  C. Klaassen,et al.  Regulation of Sulfotransferase Enzymes by Prototypical Microsomal Enzyme Inducers in Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.

[56]  Xingguo Cheng,et al.  TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS) , 2005, Drug Metabolism and Disposition.

[57]  C. Klaassen,et al.  Effects of butylated hydroxyanisole on acetaminophen hepatotoxicity and glucuronidation in vivo. , 1986, Toxicology and applied pharmacology.

[58]  M. Sporn,et al.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. , 2007, Antioxidants & redox signaling.

[59]  P. Bugnon,et al.  The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis , 2008, Laboratory Investigation.

[60]  W. Berkel,et al.  Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. , 2006, Chemical research in toxicology.

[61]  C. Klaassen,et al.  Induction of Mouse UDP-Glucuronosyltransferase mRNA Expression in Liver and Intestine by Activators of Aryl-Hydrocarbon Receptor, Constitutive Androstane Receptor, Pregnane X Receptor, Peroxisome Proliferator-Activated Receptor α, and Nuclear Factor Erythroid 2-Related Factor 2 , 2009, Drug Metabolism and Disposition.

[62]  K. Itoh,et al.  Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression* , 2003, Journal of Biological Chemistry.

[63]  W. Jakoby,et al.  Redox control of aryl sulfotransferase specificity. , 2000, Archives of biochemistry and biophysics.

[64]  C. Klaassen,et al.  CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. , 2009, Toxicology and applied pharmacology.

[65]  S. Choudhuri,et al.  Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein. , 1993, The Journal of pharmacology and experimental therapeutics.

[66]  V. Catania,et al.  GALACTOSAMINE PREVENTS ETHINYLESTRADIOL-INDUCED CHOLESTASIS , 2006, Drug Metabolism and Disposition.

[67]  Jonathan P. Jackson,et al.  The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor , 2008, Drug Metabolism and Disposition.

[68]  R. Mulcahy,et al.  An Electrophile Responsive Element (EpRE) Regulates β-Naphthoflavone Induction of the Human γ-Glutamylcysteine Synthetase Regulatory Subunit Gene , 1998, The Journal of Biological Chemistry.

[69]  M. Sporn,et al.  Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes , 2006, Molecular Cancer Therapeutics.

[70]  C. Wolf,et al.  The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. , 2000, Biochemical Society transactions.

[71]  M. Sporn,et al.  Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin , 2009, Molecules and cells.

[72]  C. Klaassen,et al.  Nrf2 activation enhances biliary excretion of sulfobromophthalein by inducing glutathione-S-transferase activity. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  Masayuki Yamamoto,et al.  Cytoprotective role of Nrf2/Keap1 system in methylmercury toxicity. , 2007, Biochemical and biophysical research communications.

[74]  C. Wolf,et al.  The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. , 2001, Cancer research.

[75]  M. Sporn,et al.  The synthetic triterpenoid 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole blocks nuclear factor-κB activation through direct inhibition of IκB kinase β , 2006, Molecular Cancer Therapeutics.

[76]  A. Kong,et al.  Molecular mechanisms of Nrf2‐mediated antioxidant response , 2009, Molecular carcinogenesis.

[77]  R. Mulcahy,et al.  An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site. , 1998, The Journal of biological chemistry.

[78]  Xingguo Cheng,et al.  TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE , 2005, Drug Metabolism and Disposition.

[79]  S. Choudhuri,et al.  Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[80]  R. Goodman,et al.  CREB-binding Protein and p300 in Transcriptional Regulation* , 2001, The Journal of Biological Chemistry.

[81]  C. Klaassen,et al.  Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[82]  L. Wang,et al.  [Protection against synergistic hepatocarcinogenesis of hepatitis B virus expression and aflatoxin B1 by antioxidant 2(3)-tert-4 -hydroxyanisole (BHA) in HBV large envelope transgenic mice]. , 1999, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[83]  J. Potter,et al.  GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES , 2005, Drug Metabolism and Disposition.

[84]  Y. Liu,et al.  Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice. , 1993, The Journal of pharmacology and experimental therapeutics.

[85]  H. Aburatani,et al.  Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. , 2006, Biochemical and biophysical research communications.

[86]  R. Mulcahy,et al.  Constitutive and β-Naphthoflavone-induced Expression of the Human γ-Glutamylcysteine Synthetase Heavy Subunit Gene Is Regulated by a Distal Antioxidant Response Element/TRE Sequence* , 1997, The Journal of Biological Chemistry.

[87]  P. Talalay Mechanisms of induction of enzymes that protect against chemical carcinogenesis. , 1989, Advances in enzyme regulation.

[88]  John F. Reichard,et al.  Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1 , 2007, Nucleic acids research.

[89]  M. Sporn,et al.  Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. , 2006, Cancer research.

[90]  J. Boyer,et al.  Nuclear factor erythroid 2–related factor 2 is a positive regulator of human bile salt export pump expression , 2009, Hepatology.

[91]  K. Itoh,et al.  High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[92]  R. Potter,et al.  The heme oxygenase system: its role in liver inflammation. , 2003, Current drug targets. Cardiovascular & haematological disorders.

[93]  Y. Kan,et al.  NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[94]  M. Kwak,et al.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[95]  C. Klaassen,et al.  NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet , 2008, Journal of Pharmacology and Experimental Therapeutics.

[96]  J. D. Engel,et al.  Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation , 2003, Nature Genetics.

[97]  M. Sporn,et al.  The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[98]  A. Cederbaum,et al.  Pyrazole induced oxidative liver injury independent of CYP2E1/2A5 induction due to Nrf2 deficiency. , 2008, Toxicology.